查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1629330

腎去神經設備市場，按技術、按產品、最終用戶、國家和地區 - 2025-2032 年全球行業分析、市場規模、市場佔有率和預測

Renal Denervation Devices Market, By Technology, By Product, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2024年，腎臟去神經設備市場規模為2.5109億美元，2025年至2032年複合年成長率為40.98%。

去腎神經設備市場-市場動態

高血壓盛行率上升

由於高血壓盛行率不斷上升，預計去腎神經裝置的市場未來將會發展。當流經動脈的血液壓力持續過高時，稱為高血壓。對於頑固性高血壓患者，去腎神經術（一種基於導管的手術）已成為可行的治療選擇。去腎交感神經術是治療高血壓的一種微創實驗性治療方法，但藥物並沒有改善。例如，2023年1月，美國密西西比州衛生部門密西西比州衛生部報告稱，2021年密西西比州約有100萬成年密西西比人（43.9%）患有高血壓。多發性硬化症的比例將高於美國（多發性硬化症：43.9%，美國：32.2%）。因此，由於高血壓發生率的上升，去腎神經裝置的市場將會擴大。

去腎神經設備市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2025-2032）每年將以 40.98% 左右的複合年成長率成長

基於技術細分，射頻消融預計將在 2024 年呈現最大市場佔有率

根據最終用戶細分，醫院是 2024 年的領先細分市場

按地區分類，北美是 2024 年的主要收入來源

去腎神經設備市場細分分析：

全球腎去神經設備市場根據技術、產品、最終用戶和地區進行細分。

根據技術，市場分為射頻消融、近距離放射治療、基於超音波能量的 RDN、化學消融等。到 2024 年，射頻消融術類別將佔據市場主導地位，因為其已建立的市場地位以及使用該技術進行的大量成功手術。這項技術自問世以來就得到了廣泛應用，它利用射頻能量來破壞過度活躍的腎臟神經。例如，印度Kavery 醫院於2024 年5 月推出了一種基於射頻的新型腎臟去神經治療方法，用於治療持續性高血壓。藥性高血壓方面顯示出良好的效果，凸顯了該技術的市場領先地位。

根據最終用戶，市場分為醫院、診所、心血管研究中心和其他。到 2024 年，醫院類別因其先進的基礎設施、高技能的人員以及複雜流程的資源而佔據主導市場佔有率。由於完善的報銷結構和支持性醫療政策使患者更容易接受最先進的治療，這些設施在處理難治性高血壓病例方面非常成功。除了核心職責外，醫院對於評估新型去腎神經療法的安全性和有效性的臨床試驗也至關重要。這項研究推動了該領域的發展，也有助於將新穎的工具和方法儘早整合到標準醫療實踐中。這些機構透過積極參與試驗並幫助開發實證程序來增強高血壓患者的治療方案。

去腎神經設備市場 - 地理洞察

2024 年，北美在去腎神經裝置行業中處於領先地位，這主要是由於顯著的技術進步和大量的 FDA 批准請求。 2023年，FDA授權「Symplicity Spyral系統和基於超音波的Paradise裝置」作為美國兩種腎臟去神經裝置之一。此外，該地區的主導地位歸因於多種因素，包括人口老化、生活方式的改變以及高血壓的高盛行率。市場的成長也主要是由生產高效設備的研發努力的增加所推動的。本地新產品的增加是推動去腎神經裝置市場成長的另一個面向。

由於手術的持久效果、高血壓發病率上升和技術進步等因素，歐洲去腎神經裝置市場預計將顯著發展。例如，根據健康改善和差異辦公室的資料，2021 年英國有8,457,600 人患有高血壓。的受訪者表示他們了解自己的血壓。此外，男性比女性更有可能自我報告患有高血壓。因此，該地區擴張的主要原因之一是高血壓盛行率的上升。

去腎神經設備市場-競爭格局：

不同產業參與者之間的激烈競爭是全球去腎神經設備市場競爭環境的決定性特徵。大型產業參與者正積極採取多種策略來擴大其全球影響力，包括Medtronic PLC、ReCor Medical Inc.（大塚控股有限公司）、St. Jude Medical Inc.（雅培實驗室）、Symple Surgical Inc.、 Ablative Solutions Inc.、Covidien PLC、Mercator MedSystems Inc. 等。此外，許多醫療設備製造商、研究機構和醫療保健提供者正在參與市場，努力為去腎神經設備提供新技術和治療策略。透過夥伴關係、協作以及研發計劃，這些參與者致力於推動該領域的發展。此外，產品創新是去腎神經裝置市場越來越受歡迎的一大趨勢。去腎神經裝置市場上的大公司正致力於創造尖端產品，以提高其地位並獲得競爭優勢。例如，美國醫療器材製造商 ReCor Medical Inc. 於 2021 年 10 月推出了 Paradise 超音波腎去神經系統，用於治療高血壓。該技術使用非聚焦超音波，以侵入性較小的方式治​​療通往腎臟的過度活躍的神經。與假手術相比，天堂系統已被證明可以成功降低血壓。

近期發展

2024 年 6 月：總部位於韓國首爾的醫療器材公司 DeepQure Inc. 表示，其已批准 FDA 的實驗器材豁免，目前正在開始 HyperQure 去腎神經 (RDN) 系統的早期可行性研究 (EFS) 。為了治療頑固性高血壓，RDN 使用血管外腹腔鏡工具 HyperQure。

2024年4月：根據Recor Medical, Inc.及其母公司大塚醫療器材有限公司發布的聲明，FDA已批准Paradise超音波腎臟去神經系統。的Al Qassimi 醫院引進中東市場。 Paradise 系統透過使用尖端超音波技術來瞄準和中斷過度活躍的腎臟神經元，提供了一種革命性的治療難治性高血壓的方法。

2023年11月：美國醫療設備企業Recor Medical推出Paradise超音波腎臟去神經療法。利用超音波技術對腎動脈周圍的交感神經進行去神經支配，這是美國第一個獲得 FDA 批准的腎去神經療法。這可以減少可能導致高血壓的過度活動。作為高血壓治療領域急需的突破，Paradise 系統在臨床測試中顯示血壓顯著下降。

目錄

第 1 章：去腎神經設備市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 去腎神經設備市場片段（按技術）
    • 腎臟去神經設備市場片段（按產品）
    • 最終用戶的腎臟去神經設備市場片段
    • 去腎神經設備市場片段（按國家/地區）
    • 按地區分類的去腎神經設備市場片段
  • 競爭洞察

第 3 章：去腎神經設備主要市場趨勢

  • 去腎神經設備市場促進因素
    • 市場促進因素的影響分析
  • 去腎神經設備市場限制
    • 市場限制影響分析
  • 去腎神經裝置的市場機會
  • 去腎神經設備市場未來趨勢

第 4 章：去腎神經裝置產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：去腎神經設備市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：去腎臟神經設備市場格局

  • 2024 年去腎神經設備市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：去腎神經設備市場 - 按技術

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 射頻消融術
    • 近距離放射治療
    • 基於超音波能量的 RDN
    • 化學消融
    • 其他

第 8 章：去腎神經設備市場 - 按產品

  • 概述
    • 按產品分類的細分市場佔有率分析
    • 單電極
    • 多電極
    • 非沖洗導管
    • 沖洗導管
    • 其他

第 9 章：腎去神經設備市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 心血管研究中心
    • 其他

第 10 章：去腎神經設備市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美去腎神經設備主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按產品）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲去腎神經設備主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模與預測（按產品）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區去腎臟神經設備主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按技術）
    • 亞太地區市場規模與預測（按產品）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 韓國
    • 日本
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲去腎神經設備主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按技術）
    • 拉丁美洲市場規模與預測（按產品）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲去腎臟神經設備主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（按產品）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 去腎神經設備產業

  • 競爭儀表板
  • 公司簡介
    • Medtronic PLC
    • ReCor Medical Inc. (Otsuka Holdings Co. Ltd)
    • St. Jude Medical Inc. (Abbott Laboratories)
    • Symple Surgical Inc.
    • Ablative Solutions Inc.
    • Covidien PLC
    • Mercator MedSystems Inc.
    • Terumo Corporation
    • Kona Medical Inc.
    • Vessix Vascular Inc. (Boston Scientific Corporation)
    • Renal Dynamics Limited
    • DeepQure
    • Johnson & Johnson Private Limited
    • Miracor Medical SA
    • SoniVie (CardioSonic, Inc.)
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4515

REPORT HIGHLIGHT

Renal Denervation Devices Market size was valued at US$ 251.09 Million in 2024, expanding at a CAGR of 40.98% from 2025 to 2032.

A minimally invasive technique called renal denervation attempts to reduce the sympathetic nervous system's activity in the kidneys. A catheter is inserted via the arteries and into the renal arteries, which provide blood to the kidneys. The gadget then sends electricity to the vessel wall's nerves to interfere with the signals that can lead to hypertension. There are several ways to provide the energy, including radiofrequency ablation, ultrasound, and, more recently, chemical injections directly or novel techniques based on percutaneous delivery systems. The growing prevalence of hypertension is one of several factors driving the market's expansion. Furthermore, during the projected period, the renal denervation devices market is anticipated to rise as a result of the growing acceptance of innovative goods. For instance, the medical device business Kalos Medical was awarded Won4.67m (about $3.5m) to develop further their renal denervation medical device for the treatment of hypertension. Technological advancements in renal denervation (RDN) products, the growing elderly population, the short-term and permanent effects of renal denervation procedures, and the rising incidence of uncontrolled and treatment-resistant or drug-resistant hypertension (trHTN) are additional factors propelling the renal denervation devices market growth.

Renal Denervation Devices Market- Market Dynamics

Rising Prevalence of Hypertension

The market for renal denervation devices is anticipated to develop in the future due to the rising prevalence of hypertension. When the force of blood flowing through the blood arteries is continuously too high, it is referred to as hypertension or high blood pressure. For patients with resistant hypertension, renal denervation-a catheter-based procedure-has become a viable treatment option. A minimally invasive, experimental treatment for hypertension that has not improved with medicines is renal denervation. For instance, in January 2023, the Mississippi State Department of Health, a Mississippi state health department situated in the United States, reported that approximately 1 million adult Mississippians (43.9%) had high blood pressure in 2021. The prevalence of hypertension was 36.3% greater in MS in 2021 than in the US (MS: 43.9%, US: 32.2%). Thus, the market for renal denervation devices will expand as a result of the rising incidence of hypertension.

Renal Denervation Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 40.98% over the forecast period (2025-2032)

Based on technology segmentation, radio frequency ablation was predicted to show maximum market share in the year 2024

Based on end-user segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Renal Denervation Devices Market- Segmentation Analysis:

The Global Renal Denervation Devices Market is segmented on the basis of Technology, Product, End-user, and Region.

On the basis of technology, the market is segregated into Radio Frequency Ablation, Brachytherapy, Ultrasound Energy-based RDN, Chemical Ablation, and Others. In 2024, the market was dominated by the radio frequency ablation category because of its established market presence and the large number of successful surgeries carried out using this technology. This technique, which has been widely used since its inception, uses radiofrequency energy to break up hyperactive renal nerves. For instance, Kauvery Hospital in India introduced a novel renal denervation treatment based on radiofrequency for persistent hypertension in May 2024. The Indian government-approved technique demonstrated promising outcomes in lowering nerve activity and treating severe, drug-resistant hypertension, highlighting the technology's market leadership.

Based on end-user, the market is divided into Hospitals, Clinics, Cardiovascular research centre, and Others. In 2024, the hospitals category held a dominant market share because of their sophisticated infrastructure, highly skilled personnel, and resources for intricate processes. Due to well-established reimbursement structures and supportive healthcare policies that make it easier for patients to receive state-of-the-art therapies, these facilities are very successful at handling cases of resistant hypertension. Hospitals are essential for clinical trials that assess the safety and effectiveness of novel renal denervation therapies, in addition to their core duties. The field is advanced by this research, which also aids in the early integration of novel tools and methods into standard medical practice. These institutes enhance treatment regimens for hypertension patients by actively engaging in trials and helping to develop evidence-based procedures.

Renal Denervation Devices Market- Geographical Insights

In 2024, North America led the renal denervation devices industry, mostly due to significant technological advancements and a high amount of FDA approval requests. In 2023, the FDA authorized the "Symplicity Spyral System and Ultrasound-based Paradise Device" as one of two renal denervation devices in the US. Furthermore, the region's dominance is attributed to a number of factors, including an ageing population, changing lifestyles, and the high prevalence of hypertension. The market's growth is also primarily driven by increasing R&D efforts to produce efficient devices. The rise in local new launches is another aspect propelling the renal denervation devices market's growth.

The market for renal denervation devices is anticipated to develop significantly in Europe due to factors like the procedure's long-lasting effects, rising rates of hypertension, and increased technological advancements. For instance, according to data from the Office of Health Improvement and Disparities, 8,457,600 people in England had hypertension in 2021. Furthermore, 73.6% of respondents to a survey done in Italy in 2021 said they were aware of their blood pressure, 42.3% said they had been diagnosed with hypertension, and 41.4% said they were taking antihypertensive drugs. Additionally, men were more likely than women to self-report having hypertension. Consequently, one of the main causes of the region's expansion is the rising prevalence of hypertension.

Renal Denervation Devices Market- Competitive Landscape:

The fierce rivalry between different industry participants is a defining feature of the competitive environment of the worldwide renal denervation devices market. Large industry participants are aggressively pursuing a number of tactics to bolster their worldwide footprint, including Medtronic PLC, ReCor Medical Inc. (Otsuka Holdings Co. Ltd), St. Jude Medical Inc. (Abbott Laboratories), Symple Surgical Inc., Ablative Solutions Inc., Covidien PLC, Mercator MedSystems Inc., and others. Furthermore, numerous medical device makers, research institutes, and healthcare providers are participating in the market in an effort to provide novel technologies and treatment strategies for renal denervation devices. Through partnerships, collaborations, and research and development initiatives, these players are committed to furthering the area. Additionally, product innovation is a major trend that is becoming more and more popular in the market for renal denervation devices. Large firms in the market for renal denervation devices are concentrating on creating cutting-edge goods to improve their standing and obtain a competitive edge. For instance, ReCor Medical Inc., a US-based manufacturer of medical devices, introduced the Paradise Ultrasound Renal Denervation System in October 2021 to treat hypertension. Using non-focused ultrasound, this technique treats hyperactive nerves that go to the kidney in a less invasive manner. When compared to a sham operation, the Paradise System has been demonstrated to lower blood pressure successfully.

Recent Development

June 2024: DeepQure Inc., a medical device business based in Seoul, South Korea, stated that it has approved an experimental device exemption from the FDA and is now beginning an early feasibility study (EFS) for the HyperQure renal denervation (RDN) system. For the treatment of resistant hypertension, RDN uses the extravascular laparoscopic tool HyperQure.

April 2024: The FDA has approved the paradise ultrasound renal denervation system, according to a statement released by Recor Medical, Inc. and its parent firm, Otsuka Medical Devices Co., Ltd. This cutting-edge technology, which is currently on the market, was recently introduced to the Middle Eastern market at Al Qassimi Hospital in Sharjah, United Arab Emirates. The Paradise system offers a revolutionary approach to treating resistant hypertension by using cutting-edge ultrasound technology to target and interrupt hyperactive renal neurons.

November 2023: The US-based medical equipment business Recor Medical introduced Paradise Ultrasound Renal Denervation Therapy. The sympathetic nerves around the renal arteries are denervated utilizing ultrasound technology, which is the first FDA-approved renal denervation therapy in the US. This reduces the overactivity that can cause hypertension. As a much-needed breakthrough in the management of hypertension, the Paradise System has demonstrated notable drops in blood pressure in clinical testing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RENAL DENERVATION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic PLC
  • ReCor Medical Inc. (Otsuka Holdings Co. Ltd)
  • St. Jude Medical Inc. (Abbott Laboratories)
  • Symple Surgical Inc.
  • Ablative Solutions Inc.
  • Covidien PLC
  • Mercator MedSystems Inc.
  • Terumo Corporation
  • Kona Medical Inc.
  • Vessix Vascular Inc. (Boston Scientific Corporation)
  • Renal Dynamics Limited
  • DeepQure
  • Johnson & Johnson Private Limited
  • Miracor Medical SA
  • SoniVie (CardioSonic, Inc.)
  • Others

GLOBAL RENAL DENERVATION DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Radio Frequency Ablation
  • Brachytherapy
  • Ultrasound Energy-based RDN
  • Chemical Ablation
  • Others

GLOBAL RENAL DENERVATION DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Single electrode
  • Multi Electrode
  • Non irrigated catheter
  • Irrigated Catheter
  • Others

GLOBAL RENAL DENERVATION DEVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Cardiovascular research centre
  • Others

GLOBAL RENAL DENERVATION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Renal Denervation Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Renal Denervation Devices Market Snippet by Technology
    • 2.1.2. Renal Denervation Devices Market Snippet by Product
    • 2.1.3. Renal Denervation Devices Market Snippet by End-user
    • 2.1.4. Renal Denervation Devices Market Snippet by Country
    • 2.1.5. Renal Denervation Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Renal Denervation Devices Key Market Trends

  • 3.1. Renal Denervation Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Renal Denervation Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Renal Denervation Devices Market Opportunities
  • 3.4. Renal Denervation Devices Market Future Trends

4. Renal Denervation Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Renal Denervation Devices Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Renal Denervation Devices Market Landscape

  • 6.1. Renal Denervation Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Renal Denervation Devices Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Radio Frequency Ablation
    • 7.1.3. Brachytherapy
    • 7.1.4. Ultrasound Energy-based RDN
    • 7.1.5. Chemical Ablation
    • 7.1.6. Others

8. Renal Denervation Devices Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 8.1.2. Single electrode
    • 8.1.3. Multi Electrode
    • 8.1.4. Non irrigated catheter
    • 8.1.5. Irrigated Catheter
    • 8.1.6. Others

9. Renal Denervation Devices Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Cardiovascular research centre
    • 9.1.5. Others

10. Renal Denervation Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Renal Denervation Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Renal Denervation Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Renal Denervation Devices Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Renal Denervation Devices Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Renal Denervation Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Renal Denervation Devices Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Medtronic PLC
    • 11.2.2. ReCor Medical Inc. (Otsuka Holdings Co. Ltd)
    • 11.2.3. St. Jude Medical Inc. (Abbott Laboratories)
    • 11.2.4. Symple Surgical Inc.
    • 11.2.5. Ablative Solutions Inc.
    • 11.2.6. Covidien PLC
    • 11.2.7. Mercator MedSystems Inc.
    • 11.2.8. Terumo Corporation
    • 11.2.9. Kona Medical Inc.
    • 11.2.10. Vessix Vascular Inc. (Boston Scientific Corporation)
    • 11.2.11. Renal Dynamics Limited
    • 11.2.12. DeepQure
    • 11.2.13. Johnson & Johnson Private Limited
    • 11.2.14. Miracor Medical SA
    • 11.2.15. SoniVie (CardioSonic, Inc.)
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us